Association between Different Types of Tea Consumption and Risk of Gynecologic Cancer: A Meta-Analysis of Cohort Studies
Nutrients · 13.01.2023 · 15 (2) · 403
DOI: 10.3390/nu15020403 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Nutrients, online erschienen am 13.01.2023. Verfasst von Fang Zheng und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Toxicology of School of Public Health and Department of Gynecologic Oncology of Women's Hospital, Zhejiang University School of Medicin…. Hauptthemen laut MEDLINE: Genital Neoplasms, Female, Ovarian Neoplasms. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, CAMS Innovation Fund for Medical Sciences, Fundamental Research Funds for the Central Universities.
Abstract (Originalsprache)
Plenty of studies have shown that tea has an effect of inhibiting gynecologic tumors. However, there still remained controversy of the association between tea and gynecologic tumors in epidemiological studies. In this study, PubMed, Embase, and Cochrane Database were used to search the literature from 1 January 1960 to 26 December 2022 to investigate the association between tea intake and gynecologic cancer risk. In total, 19 cohort studies with 2,020,980 subjects and 12,155 gynecological tumor cases were retrieved. The pooled relative risk (RR) of gynecologic tumor for tea intake was 1.00 (95% CI: 0.96–1.04). RRs were 0.94 (95% CI: 0.88–1.01) for ovarian cancer, 1.02 (95% CI: 0.97–1.07) for endometrial cancer, and 1.06 (95% CI: 0.91–1.23) for cervical cancer. Subgroup analyses were adopted based on the tea type and geographic location. Interestingly, significant preventive impact of non-herbal tea on ovarian cancer (pooled relative risk: 0.67; 95% CI: 0.55–0.81) was found, especially for black tea (pooled relative risk: 0.64; 95% CI: 0.51–0.80). Dose–response analysis indicated that although it is not statistically significant, a decreasing trend of ovarian cancer risk could be observed when the tea consumption was 1.40 to 3.12 cups/day. In conclusion, our findings suggested that ovarian cancer, but not other gynecologic cancers, could possibly be prevented by drinking non-herbal tea. In addition, the preventive impact of green tea on gynecologic cancer seemed to be relatively weak and needs further cohorts to validate it.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Toxicology of School of Public Health and Department of Gynecologic Oncology of Women's Hospital, Zhejiang University School of Medicine, Hangzhou 310058, China.
- Department of Gynecologic Oncology of Women's Hospital, Zhejiang University School of Medicine, Hangzhou 310058, China.
- Research Unit of Intelligence Classification of Tumor Pathology and Precision Therapy, Chinese Academy of Medical Sciences (2019RU042), Hangzhou 310058, China.
- Cancer Center, Zhejiang University, Hangzhou 310058, China.
Förderung
- National Natural Science Foundation of China
- CAMS Innovation Fund for Medical Sciences
- Fundamental Research Funds for the Central Universities
Zitieren
APA
Zheng, F., Chen, K., Zhong, J., Tang, S., Xu, S., Lu, W., Wu, Y., & Xia, D. (2023). Association between Different Types of Tea Consumption and Risk of Gynecologic Cancer: A Meta-Analysis of Cohort Studies. Nutrients, 15(2), 403. https://doi.org/10.3390/nu15020403
Vancouver
Zheng F, Chen K, Zhong J, Tang S, Xu S, Lu W, et al. Association between Different Types of Tea Consumption and Risk of Gynecologic Cancer: A Meta-Analysis of Cohort Studies. Nutrients. 2023;15(2):403. doi:10.3390/nu15020403
BibTeX
@article{Zheng2023,
author = {Zheng, Fang and Chen, Kelie and Zhong, Jiamin and Tang, Song and Xu, Sinan and Lu, Weiguo and Wu, Yihua and Xia, Dajing},
title = {Association between Different Types of Tea Consumption and Risk of Gynecologic Cancer: A Meta-Analysis of Cohort Studies},
journal = {Nutrients},
year = {2023},
volume = {15},
number = {2},
pages = {403},
doi = {10.3390/nu15020403}
}
EUVIMED